🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Sensodyne

8 posts
Read More

Haleon (HLN) near 319p: Does a 15% share-price crash make its valuation attractive after the growth downgrade?

Haleon plc shares suffered a 15% selloff after the consumer healthcare group reduced its 2026 organic revenue growth forecast to approximately 2.5%. With a valuation near 17.6 times trailing reported earnings, strong oral healthcare sales and another £500 million share buyback, investors must determine whether the correction reflects temporary disruption or a more fundamental deterioration in growth expectations.

Subscribe